As of 2025-12-17, the Relative Valuation of Enanta Pharmaceuticals Inc (ENTA) is (48.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.85 USD, the upside of Enanta Pharmaceuticals Inc based on Relative Valuation is -429.6%.
The range of the Relative Valuation is (48.01) - (51.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 21.9x | 17.1x |
| Forward P/E multiples | 16.9x - 18.2x | 17.4x |
| Fair Price | (48.01) - (51.76) | (48.95) |
| Upside | -423.3% - -448.5% | -429.6% |
| Date | P/E |
| 2025-12-15 | -5.24 |
| 2025-12-12 | -5.19 |
| 2025-12-11 | -4.98 |
| 2025-12-10 | -5.06 |
| 2025-12-09 | -5.16 |
| 2025-12-08 | -5.00 |
| 2025-12-05 | -5.15 |
| 2025-12-04 | -4.97 |
| 2025-12-03 | -5.02 |
| 2025-12-02 | -4.92 |
| 2025-12-01 | -4.98 |
| 2025-11-28 | -4.98 |
| 2025-11-26 | -4.91 |
| 2025-11-25 | -4.81 |
| 2025-11-24 | -4.81 |
| 2025-11-21 | -4.49 |
| 2025-11-20 | -4.27 |
| 2025-11-19 | -4.27 |
| 2025-11-18 | -4.36 |
| 2025-11-17 | -4.52 |
| 2025-11-14 | -4.25 |
| 2025-11-13 | -4.13 |
| 2025-11-12 | -4.20 |
| 2025-11-11 | -4.24 |
| 2025-11-10 | -4.06 |
| 2025-11-07 | -3.87 |
| 2025-11-06 | -3.81 |
| 2025-11-05 | -3.85 |
| 2025-11-04 | -3.81 |
| 2025-11-03 | -3.81 |
| 2025-10-31 | -3.86 |
| 2025-10-30 | -3.83 |
| 2025-10-29 | -3.75 |
| 2025-10-28 | -3.69 |
| 2025-10-27 | -3.70 |
| 2025-10-24 | -3.70 |
| 2025-10-23 | -3.76 |
| 2025-10-22 | -3.70 |
| 2025-10-21 | -3.88 |
| 2025-10-20 | -3.92 |
| 2025-10-17 | -3.88 |
| 2025-10-16 | -4.01 |
| 2025-10-15 | -4.12 |
| 2025-10-14 | -3.86 |
| 2025-10-13 | -4.05 |
| 2025-10-10 | -3.88 |
| 2025-10-09 | -4.04 |
| 2025-10-08 | -3.98 |
| 2025-10-07 | -3.90 |
| 2025-10-06 | -4.00 |